South Centre Statement on the extension of the TRIPS waiver for diagnostics and therapeutics for COVID-19 (9 January 2023)

Developing countries should consider options that can be implemented now to deal with IP barriers to expand production and access to COVID-19 therapeutics and diagnostics, while the so far elusive decision on whether to extend a TRIPS waiver to cover these products is taken by WTO.

https://www.southcentre.int/statement-on-extension-of-trips-waiver-for-covid-19-diagnostics-therapeutics-9-january-2023/ #COVID19 #access2meds #TRIPSwaiver